Compositions And Methods For Treating Bone Injury - EP3852820

The patent EP3852820 was granted to Board OF Regents on Nov 20, 2024. The application was originally filed on Sep 17, 2019 under application number EP19861389A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3852820

BOARD OF REGENTS
Application Number
EP19861389A
Filing Date
Sep 17, 2019
Status
Granted And Under Opposition
Oct 18, 2024
Grant Date
Nov 20, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERA ISTRAZIVANJA DOOAug 19, 2025ADMISSIBLE

Patent Citations (24) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
EXAMINATIONEP3697459
EXAMINATIONUS2009317438
INTERNATIONAL-SEARCH-REPORTUS2012190832
INTERNATIONAL-SEARCH-REPORTUS2017189538
INTERNATIONAL-SEARCH-REPORTUS2018051093
INTERNATIONAL-SEARCH-REPORTUS7348411
INTERNATIONAL-SEARCH-REPORTUS9320653
INTERNATIONAL-SEARCH-REPORTWO9603432
INTERNATIONAL-SEARCH-REPORTWO9617633
OPPOSITIONUS2009317438
OPPOSITIONUS2017128617
OTHEREP2049040
OTHEREP3697459
OTHERUS10960109
OTHERUS11596712
OTHERUS11642437
OTHERUS2009317438
OTHERUS2014271610
OTHERUS2017128617
OTHERUS8197840
OTHERWO2008011192
OTHERWO2019076484
SEARCHUS2017128617
SEARCHWO2019076484

Non-Patent Literature (NPL) Citations (37) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- XP93169919, XP093169919-
EXAMINATION- XP93169922, XP093169922-
EXAMINATION- Lovorka Grgurevic, "Recombinant Human Bone Morphogenetic Protein 6 Delivered Within Autologous Blood Coagulum Restores Critical Size Segmental Defects of Ulna in Rabbits", JBMR Plus, vol. 3, no. 5, doi:10.1002/jbm4.10085, ISSN 2473-4039, (20181105), URL: https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjbm4.10085, XP093169906
EXAMINATION- CATHARINA CHIARI, "Recombinant Human BMP6 Applied Within Autologous Blood Coagulum Accelerates Bone Healing: Randomized Controlled Trial in High Tibial Osteotomy Patients", JOURNAL OF BONE AND MINERAL RESEARCH, US, vol. 35, no. 10, doi:10.1002/jbmr.4107, ISSN 0884-0431, (20200616), pages 1893 - 1903, URL: https://onlinelibrary.wiley.com/doi/full-xml/10.1002/jbmr.4107, XP093169872
EXAMINATION- SLOBODAN VUKICEVIC, "Autologous blood coagulum is a physiological carrier for BMP6 to induce new bone formation and promote posterolateral lumbar spine fusion in rabbits", JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, US, vol. 14, no. 1, doi:10.1002/term.2981, ISSN 1932-6254, (20191110), pages 147 - 159, URL: https://onlinelibrary.wiley.com/doi/full-xml/10.1002/term.2981, XP093169900
EXAMINATION- Jelena Brkljacic, "Exogenous heparin binds and inhibits bone morphogenetic protein 6 biological activity", INTERNATIONAL ORTHOPEADICS, DE, vol. 37, no. 3, doi:10.1007/s00264-012-1714-3, ISSN 0341-2695, (20130110), pages 529 - 541, URL: http://link.springer.com/article/10.1007/s00264-012-1714-3/fulltext.html, XP093169865
EXAMINATION- Slobodan Vukicevic, "The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing", INTERNATIONAL ORTHOPEADICS, DE, vol. 38, no. 3, doi:10.1007/s00264-013-2201-1, ISSN 0341-2695, (20131219), pages 635 - 647, URL: http://link.springer.com/article/10.1007/s00264-013-2201-1/fulltext.html, XP093169898
EXAMINATION- STOKOVIC NIKOLA ET AL, "Synthetic ceramic macroporous blocks as a scaffold in ectopic bone formation induced by recombinant human bone morphogenetic protein 6 within autologous blood coagulum in rats", INTERNATIONAL ORTHOPEADICS, SPRINGER, BERLIN, DE, vol. 45, no. 4, doi:10.1007/S00264-020-04847-9, ISSN 0341-2695, (20201014), pages 1097 - 1107, (20201014), XP037425800
EXAMINATION- DURDEVIC DRAGAN ET AL, "A novel autologous bone graft substitute comprised of rhBMP6 blood coagulum as carrier tested in a randomized and controlled Phase I trial in patients with distal radial fractures", BONE, PERGAMON PRESS., OXFORD, GB, vol. 140, doi:10.1016/J.BONE.2020.115551, ISSN 8756-3282, (20200727), (20200727), XP086267598
EXAMINATION- VAIDA GLATT, "Biomimetic Hematoma as a Novel Delivery Vehicle for rhBMP-2 to Potentiate the Healing of Nonunions and Bone Defects", JOURNAL OF ORTHOPAEDIC TRAUMA, US, (20231101), vol. 37, no. 11S, doi:10.1097/BOT.0000000000002692, ISSN 0890-5339, pages S33 - S39, XP093169883
EXAMINATION- Götz Nowak, "The Ecarin Clotting Time, a Universal Method to Quantify Direct Thrombin Inhibitors", Pathophysiology of Haemost Thrombosis, CH, vol. 33, no. 4, doi:10.1159/000081505, ISSN 1424-8832, (20030101), pages 173 - 183, URL: https://www.karger.com/Article/Pdf/81505, XP093169903
INTERNATIONAL-SEARCH-REPORT- VAN ROOY et al., "Platelet hyperactivity and fibrin clot structure in transient ischemic attack individuals in the presence of metabolic syndrome: a microscopy and thromboelastography® study", Cardiovascular Diabetology, (20150000), vol. 14, no. 86, XP021227124 [Y] 1-5, 7-26 * , entire document *
OPPOSITION- Glatt Vaida, Anna Woloszyk, Kevin Tetsworth, "Mimicking the structure of fracture hematomas using snake venom enzymes for the creation of ex vivo natural designer scaffolds to enhance bone repair", Journal of Limb Lengthening & Reconstruction, (20170701), vol. 3, no. 1, pages S1 - S2, XP093308263-
OPPOSITION- Glatt Vaida, Friis Thor, Woloszyk Anna, Masci Paul, Tetsworth Kevin, "P816 Mimicking the structure of fracture hematomas using snake venom enzymes for the creation of an ex vivo natural designer scaffold to enhance bone repair", eCM Meeting Abstracts 2017, Collection 2; TERMIS EU (P816), (20170101), page P816, XP093308267-
OPPOSITION- Wang Xin, Friis Thor, Glatt Vaida, Crawford Ross, Xiao Yin, "Structural properties of fracture haematoma: current status and future clinical implications : Structural properties of fracture haematoma", JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, John Wiley & Sons, US, US , (20171001), vol. 11, no. 10, doi:10.1002/term.2190, ISSN 1932-6254, pages 2864 - 2875, XP093308281
OPPOSITION- Dumic-Cule Ivo; Peric Mihaela; Kucko Lucija; Grgurevic Lovorka; Pecina Marko; Vukicevic Slobodan, "Bone morphogenetic proteins in fracture repair", INTERNATIONAL ORTHOPEADICS, SPRINGER, BERLIN, DE, DE , (20180915), vol. 42, no. 11, doi:10.1007/s00264-018-4153-y, ISSN 0341-2695, pages 2619 - 2626, XP036613660
OPPOSITION- Anna Jonebring; Ute Lange; Elke Bucha; Johanna Deinum; Margareta Elg; Ann Lövgren, "Expression and Characterization of Recombinant Ecarin", Journal of Protein Chemistry, Kluwer Academic Publishers-Plenum Publishers, Ne, Ne , (20120417), vol. 31, no. 5, doi:10.1007/s10930-012-9409-6, ISSN 1573-4943, pages 353 - 358, XP035074605
OPPOSITION- Kuber Sampath, "Discovery of bone morphogenetic proteins - Ahistorical perspective", Bone, (2020), vol. 140, doi:10.1016/j.bone.2020.115548, XP086267595
OPPOSITION- James Aaron W., Lachaud Gregory, Shen Jia, Asatrian Greg, Nguyen Vi, Zhang Xinli, Ting Kang, Soo Chia, "A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2", Tissue engineering Part B, Mary Ann Liebert, Inc. Publishers, US, US , (20160801), vol. 22, no. 4, doi:10.1089/ten.teb.2015.0357, ISSN 1937-3368, pages 284 - 297, XP093308285
OPPOSITION- MANN, "Citrate anticoagulation and the dynamics of thrombin generation", Journal of Thrombosis and Haemostasis, (2007), vol. 5, doi:10.1111/j.1538-7836.2007.02710.x, XP093272185
OPPOSITION- Inna Shehter-Harkavyk, "On the relationship between the adhesive properties and the structural features of fibrin sealants", Journal of Adhesion Science and Technology, (20120402), vol. 18, no. 12, doi:10.1163/1568561042323220, pages 1415 - 1425, XP093175043
OPPOSITION- Ratnoff Oscar D., Potts Albert M., "THE ACCELERATING EFFECT OF CALCIUM AND OTHER CATIONS ON THE CONVERSION OF FIBRINOGEN TO FIBRIN 1", Journal of Clinical Investigation, American Society for Clinical Investigation, (19540201), vol. 33, no. 2, doi:10.1172/JCI102886, ISSN 0021-9738, pages 206 - 210, XP093308288
OPPOSITION- Brass Eric P., Forman Walter B., Edwards Robert V., Lindan Olgierd, "Fibrin Formation: Effect of Calcium Ions", Blood, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL, (19781001), vol. 52, no. 4, doi:10.1182/blood.V52.4.654.654, ISSN 0006-4971, pages 654 - 658, XP093308301
OPPOSITION- Mia-Jeanne van Rooy, "Platelet hyperactivity and fibrin clot structure in transient ischemic attack individuals in the presence of metabolic syndrome: a microscopy and thromboelastography study", Cardiovascular Diabetology, (2015), vol. 14, no. 1, doi:10.1186/s12933-015-0249-5, XP021227124
OPPOSITION- Preininger B, Gerigk H, Bruckner J, Perka C, Schell H, Ellinghaus A, Schmidt-Bleek K, Duda G, "An experimental setup to evaluate innovative therapy options for the enhancement of bone healing using BMP as a benchmark - a pilot study", European Cells and Materials, vol. 23, doi:10.22203/eCM.v023a20, pages 262 - 272, XP093308278
OPPOSITION- Cortelazzo Alessio, Guerranti Roberto, Bini Luca, Hope-Onyekwere Nnadozie, Muzzi Chiara, Leoncini Roberto, Pagani Roberto, "Effects of snake venom proteases on human fibrinogen chains", Blood Transfusion, S I M T I Servizi srl, Italy, Italy , (20100601), vol. 8, no. 3, doi:10.2450/2010.019S, ISSN 1723-2007, pages s120 - s125, XP093308295
OPPOSITION- Lövgren Ann, "Recombinant snake venom prothrombin activators", Bioengineered, Landes Bioscience, US, US , (20130501), vol. 4, no. 3, doi:10.4161/bioe.22676, ISSN 2165-5979, pages 153 - 157, XP093308298
OTHER- NOWAK GOETZ, "The ecarin clotting time, a universal method to quantify direct thrombin inhibitors", Pathophysiology of Haemost Thrombosis, CH , (20030101), vol. 33, no. 4, ISSN 1424-8832, pages 173 - 183, XP002451736-
OTHER- Lovorka Grgurevic, "Recombinant Human Bone Morphogenetic Protein 6 Delivered Within Autologous Blood Coagulum Restores Critical Size Segmental Defects of Ulna in Rabbits", JBMR Plus, (20190501), vol. 3, no. 5, doi:10.1002/jbm4.10085, ISSN 2473-4039, XP093169906
OTHER- Slobodan Vukicevic, "Autologous blood coagulum is a physiological carrier for BMP6 to induce new bone formation and promote posterolateral lumbar spine fusion in rabbits", JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, US , (20200101), vol. 14, no. 1, doi:10.1002/term.2981, ISSN 1932-6254, pages 147 - 159, XP093169900
OTHER- Jelena Brkljacic, "Exogenous heparin binds and inhibits bone morphogenetic protein 6 biological activity", INTERNATIONAL ORTHOPEADICS, DE , (20130301), vol. 37, no. 3, doi:10.1007/s00264-012-1714-3, ISSN 0341-2695, pages 529 - 541, XP093169865
OTHER- Slobodan Vukicevic, "The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing", INTERNATIONAL ORTHOPEADICS, DE , (20140301), vol. 38, no. 3, doi:10.1007/s00264-013-2201-1, ISSN 0341-2695, pages 635 - 647, XP093169898
OTHER- Stokovic Nikola; Ivanjko Natalia; Milesevic Marina; Matic Jelic Ivona; Bakic Kristian; Rumenovic Viktorija; Oppermann Hermann; Shimp Larry; Sampath T. Kuber; Pecina Marko; Vukicevic Slobodan, "Synthetic ceramic macroporous blocks as a scaffold in ectopic bone formation induced by recombinant human bone morphogenetic protein 6 within autologous blood coagulum in rats", INTERNATIONAL ORTHOPEADICS, DE , (20201014), vol. 45, no. 4, doi:10.1007/s00264-020-04847-9, ISSN 0341-2695, pages 1097 - 1107, XP037425800
OTHER- Durdevic Dragan; Vlahovic Tomislav; Pehar Sanja; Miklic Dina; Oppermann Hermann; Bordukalo-Niksic Tatjana; Gavrankapetanovic Ismet; Jamakosmanovic Mehmed; Milosevic Milan; Martinovic Snjezana; Sampath T. Kuber; Peric Mihaela; Grgurevic Lovorka; Vukicevic Slobodan, "A novel autologous bone graft substitute comprised of rhBMP6 blood coagulum as carrier tested in a randomized and controlled Phase I trial in patients with distal radial fractures", Bone, GB , (20200727), vol. 140, doi:10.1016/j.bone.2020.115551, ISSN 8756-3282, XP086267598
OTHER- Vaida Glatt, "Biomimetic Hematoma as a Novel Delivery Vehicle for rhBMP-2 to Potentiate the Healing of Nonunions and Bone Defects", JOURNAL OF ORTHOPAEDIC TRAUMA, US , (20231101), vol. 37, no. 11S, doi:10.1097/BOT.0000000000002692, ISSN 0890-5339, pages S33 - S39, XP093169883
OTHER- Shehter-Harkavyk Inna, Bianco-Peled Havazelet, "On the relationship between the adhesive properties and the structural features of fibrin sealants", Journal of Adhesion Science and Technology, GB , (20040101), vol. 18, no. 12, doi:10.1163/1568561042323220, ISSN 0169-4243, pages 1415 - 1425, XP093175043
SEARCH- MIA-JEANNE VAN ROOY ET AL, "Platelet hyperactivity and fibrin clot structure in transient ischemic attack individuals in the presence of metabolic syndrome: a microscopy and thromboelastography ? study", CARDIOVASC DIABETOLOGY, BIOMED CENTRAL, LONDON, GB, (20150704), vol. 14, no. 1, doi:10.1186/S12933-015-0249-5, ISSN 1475-2840, page 86, XP021227124 [X] 1-3,9-15 * page 3, column 2, paragraph 3 * * page 4, column 1, paragraph 2 - paragraph 3 * * page 5, column 1, paragraph 2 * * page 6, column 2, paragraph 1 * [A] 5

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents